CXCR4 is of particular interest in chronic lymphocytic leukemia (CLL) and diffuse large B-cell lymphoma (DLBCL), having been associated with adverse prognosis in both diseases [14, 15]. This evidence concerns the gene CXCR4 and diffuse large B-cell lymphoma.